SARS-CoV-2 Spike glycoprotein, 1220-1228


This peptide is derived from severe acute respiratory syndrome coronavirus 2(SARS-Cov-2), Spike glycoprotein (Uniprot No: P0DTC2). Antigen Peptide FIAGLIAIV, probable allele specificity HLA-A2;HLA-A*02:01, for stimulation of antigen-specific T cells in T cell assays.


  • General
  • References
  • Comments (0)
  • Name SARS-CoV-2 Spike glycoprotein, 1220-1228
    Category COVID-19
    One Letter Code FIAGLIAIV
    Three Letter Code {PHE}{ILE}{ALA}{GLY}{LEU}{ILE}{ALA}{ILE}{VAL}
    Molecular Weight 916.160
    Application T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
    1. Grifoni, Alba, et al. "A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2." Cell host & microbe (2020).
    2. Lee, Chloe Hyun-Jung, and Hashem Koohy. "In silico identification of vaccine targets for 2019-nCoV." F1000Research 9 (2020).
  • #[first_name]